ヘマトロジー制御の世界市場2023年:3液ヘマトロジー制御、5液ヘマトロジー制御、その他

■ 英語タイトル:Global Hematology Controls Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR23MA7942)■ 発行会社/調査会社:QYResearch
■ 商品コード:QYR23MA7942
■ 発行日:2023年3月
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:87
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥440,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ヘマトロジー制御の世界市場2023年:3液ヘマトロジー制御、5液ヘマトロジー制御、その他]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本調査資料はヘマトロジー制御のグローバル市場について調査・分析し、世界のヘマトロジー制御市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析(3液ヘマトロジー制御、5液ヘマトロジー制御、その他)、用途別セグメント分析(病院、研究所、その他)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sysmex、Danaher、Bio-Rad、Mindray、Abbott、Horiba、Boule、Diatronなどが含まれています。ヘマトロジー制御のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。新型コロナとロシア・ウクライナ戦争の影響は、ヘマトロジー制御市場規模を算出する際に考慮しました。

・ヘマトロジー制御市場の概要
- 製品の定義
- ヘマトロジー制御の種類別セグメント
- 世界のヘマトロジー制御市場規模:タイプ別分析(3液ヘマトロジー制御、5液ヘマトロジー制御、その他)
- ヘマトロジー制御の用途別セグメント
- 世界のヘマトロジー制御市場規模:用途別分析(病院、研究所、その他)
- 世界のヘマトロジー制御市場規模予測(2018年-2029年)
- ヘマトロジー制御の平均価格推移(2018年-2029年)
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ヘマトロジー制御市場の競争状況およびトレンド

・ヘマトロジー制御の地域別市場規模
- 北米のヘマトロジー制御市場規模(2018年-2029年)
- 米国のヘマトロジー制御市場規模(2018年-2029年)
- ヨーロッパのヘマトロジー制御市場規模(2018年-2029年)
- アジア太平洋のヘマトロジー制御市場規模(2018年-2029年)
- 中国のヘマトロジー制御市場規模(2018年-2029年)
- 日本のヘマトロジー制御市場規模(2018年-2029年)
- 韓国のヘマトロジー制御市場規模(2018年-2029年)
- インドのヘマトロジー制御市場規模(2018年-2029年)
- オーストラリアのヘマトロジー制御市場規模(2018年-2029年)
- 中南米のヘマトロジー制御市場規模(2018年-2029年)
- 中東・アフリカのヘマトロジー制御市場規模(2018年-2029年)

・種類別セグメント:3液ヘマトロジー制御、5液ヘマトロジー制御、その他
- 世界のヘマトロジー制御のタイプ別販売量(2018年-2023年)
- 世界のヘマトロジー制御のタイプ別売上(2018年-2023年)
- 世界のヘマトロジー制御のタイプ別価格

・用途別セグメント:病院、研究所、その他
- 世界のヘマトロジー制御の用途別販売量(2018年-2023年)
- 世界のヘマトロジー制御の用途別売上(2018年-2023年)
- 世界のヘマトロジー制御の用途別価格

・主要企業のプロファイル:企業情報、事業概要、売上、製品ポートフォリオ、動向
Sysmex、Danaher、Bio-Rad、Mindray、Abbott、Horiba、Boule、Diatron

・産業チェーンと販売チャネルの分析
- ヘマトロジー制御産業チェーン分析
- ヘマトロジー制御の主要原材料
- ヘマトロジー制御の販売チャネル
- ヘマトロジー制御のディストリビューター
- ヘマトロジー制御の主要顧客

・ヘマトロジー制御市場ダイナミクス
- ヘマトロジー制御の業界動向
- ヘマトロジー制御市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Hematology controls are used to assess the precision of instruments such as hematology analyzers, thereby ensuring valid patient results and fulfilling accreditation requirements. The controls are commonly found in the clinical diagnostics laboratory.
Highlights
The global Hematology Controls market was valued at US$ 323.3 million in 2022 and is anticipated to reach US$ 518.6 million by 2029, witnessing a CAGR of 6.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key players of Hematology Controls include Sysmex, Danaher, etc. Global top 3 companies hold a share about 70%. Asia Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 3-Part is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospital, with a share over 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hematology Controls, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Controls.
The Hematology Controls market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hematology Controls market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Controls manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Sysmex
Danaher
Bio-Rad
Mindray
Abbott
Horiba
Boule
Diatron
Segment by Type
3-Part Hematology Controls
5-Part Hematology Controls
Others
Segment by Application
Hospital
Independent Lab
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Controls manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hematology Controls market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematology Controls market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hematology Controls and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hematology Controls industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematology Controls.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Controls manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Hematology Controls Market Overview
1.1 Product Overview and Scope of Hematology Controls
1.2 Hematology Controls Segment by Type
1.2.1 Global Hematology Controls Market Value Comparison by Type (2023-2029)
1.2.2 3-Part Hematology Controls
1.2.3 5-Part Hematology Controls
1.2.4 Others
1.3 Hematology Controls Segment by Application
1.3.1 Global Hematology Controls Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Independent Lab
1.3.4 Others
1.4 Global Hematology Controls Market Size Estimates and Forecasts
1.4.1 Global Hematology Controls Revenue 2018-2029
1.4.2 Global Hematology Controls Sales 2018-2029
1.4.3 Global Hematology Controls Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hematology Controls Market Competition by Manufacturers
2.1 Global Hematology Controls Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hematology Controls Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hematology Controls Average Price by Manufacturers (2018-2023)
2.4 Global Hematology Controls Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hematology Controls, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hematology Controls, Product Type & Application
2.7 Hematology Controls Market Competitive Situation and Trends
2.7.1 Hematology Controls Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hematology Controls Players Market Share by Revenue
2.7.3 Global Hematology Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hematology Controls Retrospective Market Scenario by Region
3.1 Global Hematology Controls Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hematology Controls Global Hematology Controls Sales by Region: 2018-2029
3.2.1 Global Hematology Controls Sales by Region: 2018-2023
3.2.2 Global Hematology Controls Sales by Region: 2024-2029
3.3 Global Hematology Controls Global Hematology Controls Revenue by Region: 2018-2029
3.3.1 Global Hematology Controls Revenue by Region: 2018-2023
3.3.2 Global Hematology Controls Revenue by Region: 2024-2029
3.4 North America Hematology Controls Market Facts & Figures by Country
3.4.1 North America Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hematology Controls Sales by Country (2018-2029)
3.4.3 North America Hematology Controls Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hematology Controls Market Facts & Figures by Country
3.5.1 Europe Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hematology Controls Sales by Country (2018-2029)
3.5.3 Europe Hematology Controls Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hematology Controls Market Facts & Figures by Country
3.6.1 Asia Pacific Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hematology Controls Sales by Country (2018-2029)
3.6.3 Asia Pacific Hematology Controls Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hematology Controls Market Facts & Figures by Country
3.7.1 Latin America Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hematology Controls Sales by Country (2018-2029)
3.7.3 Latin America Hematology Controls Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hematology Controls Market Facts & Figures by Country
3.8.1 Middle East and Africa Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hematology Controls Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hematology Controls Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hematology Controls Sales by Type (2018-2029)
4.1.1 Global Hematology Controls Sales by Type (2018-2023)
4.1.2 Global Hematology Controls Sales by Type (2024-2029)
4.1.3 Global Hematology Controls Sales Market Share by Type (2018-2029)
4.2 Global Hematology Controls Revenue by Type (2018-2029)
4.2.1 Global Hematology Controls Revenue by Type (2018-2023)
4.2.2 Global Hematology Controls Revenue by Type (2024-2029)
4.2.3 Global Hematology Controls Revenue Market Share by Type (2018-2029)
4.3 Global Hematology Controls Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hematology Controls Sales by Application (2018-2029)
5.1.1 Global Hematology Controls Sales by Application (2018-2023)
5.1.2 Global Hematology Controls Sales by Application (2024-2029)
5.1.3 Global Hematology Controls Sales Market Share by Application (2018-2029)
5.2 Global Hematology Controls Revenue by Application (2018-2029)
5.2.1 Global Hematology Controls Revenue by Application (2018-2023)
5.2.2 Global Hematology Controls Revenue by Application (2024-2029)
5.2.3 Global Hematology Controls Revenue Market Share by Application (2018-2029)
5.3 Global Hematology Controls Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sysmex
6.1.1 Sysmex Corporation Information
6.1.2 Sysmex Description and Business Overview
6.1.3 Sysmex Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sysmex Hematology Controls Product Portfolio
6.1.5 Sysmex Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Corporation Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Danaher Hematology Controls Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Bio-Rad
6.3.1 Bio-Rad Corporation Information
6.3.2 Bio-Rad Description and Business Overview
6.3.3 Bio-Rad Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bio-Rad Hematology Controls Product Portfolio
6.3.5 Bio-Rad Recent Developments/Updates
6.4 Mindray
6.4.1 Mindray Corporation Information
6.4.2 Mindray Description and Business Overview
6.4.3 Mindray Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mindray Hematology Controls Product Portfolio
6.4.5 Mindray Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abbott Hematology Controls Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Horiba
6.6.1 Horiba Corporation Information
6.6.2 Horiba Description and Business Overview
6.6.3 Horiba Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Horiba Hematology Controls Product Portfolio
6.6.5 Horiba Recent Developments/Updates
6.7 Boule
6.6.1 Boule Corporation Information
6.6.2 Boule Description and Business Overview
6.6.3 Boule Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boule Hematology Controls Product Portfolio
6.7.5 Boule Recent Developments/Updates
6.8 Diatron
6.8.1 Diatron Corporation Information
6.8.2 Diatron Description and Business Overview
6.8.3 Diatron Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Diatron Hematology Controls Product Portfolio
6.8.5 Diatron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hematology Controls Industry Chain Analysis
7.2 Hematology Controls Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hematology Controls Production Mode & Process
7.4 Hematology Controls Sales and Marketing
7.4.1 Hematology Controls Sales Channels
7.4.2 Hematology Controls Distributors
7.5 Hematology Controls Customers
8 Hematology Controls Market Dynamics
8.1 Hematology Controls Industry Trends
8.2 Hematology Controls Market Drivers
8.3 Hematology Controls Market Challenges
8.4 Hematology Controls Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Hematology Controls Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Hematology Controls Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Hematology Controls Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hematology Controls Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Hematology Controls Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hematology Controls Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hematology Controls Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hematology Controls Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hematology Controls, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Hematology Controls, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hematology Controls, Product Type & Application
Table 12. Global Key Manufacturers of Hematology Controls, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hematology Controls by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Controls as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hematology Controls Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hematology Controls Sales by Region (2018-2023) & (K Units)
Table 18. Global Hematology Controls Sales Market Share by Region (2018-2023)
Table 19. Global Hematology Controls Sales by Region (2024-2029) & (K Units)
Table 20. Global Hematology Controls Sales Market Share by Region (2024-2029)
Table 21. Global Hematology Controls Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hematology Controls Revenue Market Share by Region (2018-2023)
Table 23. Global Hematology Controls Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hematology Controls Revenue Market Share by Region (2024-2029)
Table 25. North America Hematology Controls Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hematology Controls Sales by Country (2018-2023) & (K Units)
Table 27. North America Hematology Controls Sales by Country (2024-2029) & (K Units)
Table 28. North America Hematology Controls Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hematology Controls Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hematology Controls Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hematology Controls Sales by Country (2018-2023) & (K Units)
Table 32. Europe Hematology Controls Sales by Country (2024-2029) & (K Units)
Table 33. Europe Hematology Controls Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hematology Controls Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hematology Controls Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hematology Controls Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Hematology Controls Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Hematology Controls Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hematology Controls Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hematology Controls Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hematology Controls Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Hematology Controls Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Hematology Controls Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hematology Controls Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hematology Controls Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hematology Controls Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Hematology Controls Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Hematology Controls Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hematology Controls Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hematology Controls Sales (K Units) by Type (2018-2023)
Table 51. Global Hematology Controls Sales (K Units) by Type (2024-2029)
Table 52. Global Hematology Controls Sales Market Share by Type (2018-2023)
Table 53. Global Hematology Controls Sales Market Share by Type (2024-2029)
Table 54. Global Hematology Controls Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Hematology Controls Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Hematology Controls Revenue Market Share by Type (2018-2023)
Table 57. Global Hematology Controls Revenue Market Share by Type (2024-2029)
Table 58. Global Hematology Controls Price (US$/Unit) by Type (2018-2023)
Table 59. Global Hematology Controls Price (US$/Unit) by Type (2024-2029)
Table 60. Global Hematology Controls Sales (K Units) by Application (2018-2023)
Table 61. Global Hematology Controls Sales (K Units) by Application (2024-2029)
Table 62. Global Hematology Controls Sales Market Share by Application (2018-2023)
Table 63. Global Hematology Controls Sales Market Share by Application (2024-2029)
Table 64. Global Hematology Controls Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hematology Controls Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hematology Controls Revenue Market Share by Application (2018-2023)
Table 67. Global Hematology Controls Revenue Market Share by Application (2024-2029)
Table 68. Global Hematology Controls Price (US$/Unit) by Application (2018-2023)
Table 69. Global Hematology Controls Price (US$/Unit) by Application (2024-2029)
Table 70. Sysmex Corporation Information
Table 71. Sysmex Description and Business Overview
Table 72. Sysmex Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sysmex Hematology Controls Product
Table 74. Sysmex Recent Developments/Updates
Table 75. Danaher Corporation Information
Table 76. Danaher Description and Business Overview
Table 77. Danaher Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Danaher Hematology Controls Product
Table 79. Danaher Recent Developments/Updates
Table 80. Bio-Rad Corporation Information
Table 81. Bio-Rad Description and Business Overview
Table 82. Bio-Rad Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bio-Rad Hematology Controls Product
Table 84. Bio-Rad Recent Developments/Updates
Table 85. Mindray Corporation Information
Table 86. Mindray Description and Business Overview
Table 87. Mindray Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Mindray Hematology Controls Product
Table 89. Mindray Recent Developments/Updates
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Abbott Hematology Controls Product
Table 94. Abbott Recent Developments/Updates
Table 95. Horiba Corporation Information
Table 96. Horiba Description and Business Overview
Table 97. Horiba Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Horiba Hematology Controls Product
Table 99. Horiba Recent Developments/Updates
Table 100. Boule Corporation Information
Table 101. Boule Description and Business Overview
Table 102. Boule Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Boule Hematology Controls Product
Table 104. Boule Recent Developments/Updates
Table 105. Diatron Corporation Information
Table 106. Diatron Description and Business Overview
Table 107. Diatron Hematology Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Diatron Hematology Controls Product
Table 109. Diatron Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Hematology Controls Distributors List
Table 113. Hematology Controls Customers List
Table 114. Hematology Controls Market Trends
Table 115. Hematology Controls Market Drivers
Table 116. Hematology Controls Market Challenges
Table 117. Hematology Controls Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hematology Controls
Figure 2. Global Hematology Controls Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Hematology Controls Market Share by Type in 2022 & 2029
Figure 4. 3-Part Hematology Controls Product Picture
Figure 5. 5-Part Hematology Controls Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hematology Controls Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Hematology Controls Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Independent Lab
Figure 11. Others
Figure 12. Global Hematology Controls Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Hematology Controls Market Size (2018-2029) & (US$ Million)
Figure 14. Global Hematology Controls Sales (2018-2029) & (K Units)
Figure 15. Global Hematology Controls Average Price (US$/Unit) & (2018-2029)
Figure 16. Hematology Controls Report Years Considered
Figure 17. Hematology Controls Sales Share by Manufacturers in 2022
Figure 18. Global Hematology Controls Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Hematology Controls Players: Market Share by Revenue in 2022
Figure 20. Hematology Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Hematology Controls Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Hematology Controls Sales Market Share by Country (2018-2029)
Figure 23. North America Hematology Controls Revenue Market Share by Country (2018-2029)
Figure 24. United States Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Hematology Controls Sales Market Share by Country (2018-2029)
Figure 27. Europe Hematology Controls Revenue Market Share by Country (2018-2029)
Figure 28. Germany Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Hematology Controls Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Hematology Controls Revenue Market Share by Region (2018-2029)
Figure 35. China Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Hematology Controls Sales Market Share by Country (2018-2029)
Figure 45. Latin America Hematology Controls Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Hematology Controls Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Hematology Controls Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Hematology Controls Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Hematology Controls by Type (2018-2029)
Figure 56. Global Revenue Market Share of Hematology Controls by Type (2018-2029)
Figure 57. Global Hematology Controls Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Hematology Controls by Application (2018-2029)
Figure 59. Global Revenue Market Share of Hematology Controls by Application (2018-2029)
Figure 60. Global Hematology Controls Price (US$/Unit) by Application (2018-2029)
Figure 61. Hematology Controls Value Chain
Figure 62. Hematology Controls Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA7942 )"ヘマトロジー制御の世界市場2023年:3液ヘマトロジー制御、5液ヘマトロジー制御、その他" (英文:Global Hematology Controls Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。